Equity to Asset ratio is calculated as total stockholders equity divided by total asset. PetVivo Holdings's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $0.90 Mil. PetVivo Holdings's Total Assets for the quarter that ended in Dec. 2023 was $3.63 Mil.
Therefore, PetVivo Holdings's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.25.
The historical rank and industry rank for PetVivo Holdings's Equity-to-Asset or its related term are showing as below:
PETV'
s Equity-to-Asset Range Over the Past 10 Years
Min: -7.11 Med: -0.07 Max: 0.86
Current: 0.25
During the past 13 years, the highest Equity to Asset Ratio of PetVivo Holdings was 0.86. The lowest was -7.11. And the median was -0.07.
PETV's Equity-to-Asset is ranked worse than 87.56% of 868
companies
in the Medical Devices & Instruments industry
Industry Median: 0.65
vs PETV: 0.25
PetVivo Holdings Equity-to-Asset Historical Data
The historical data trend for PetVivo Holdings's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of PetVivo Holdings's Equity-to-Asset
For the Medical Devices subindustry, PetVivo Holdings's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PetVivo Holdings's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PetVivo Holdings's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where PetVivo Holdings's Equity-to-Asset falls into.
PetVivo Holdings Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
PetVivo Holdings's Equity to Asset Ratio for the fiscal year that ended in Mar. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
PetVivo Holdings Equity-to-Asset Related Terms
Thank you for viewing the detailed overview of PetVivo Holdings's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
PetVivo Holdings (PetVivo Holdings) Business Description
PetVivo Holdings Inc is an emerging biomedical device company. The group is focused on the manufacturing, commercialization, and licensing of medical devices and therapeutics for companion animals. A key strategy of the company is to leverage human therapies for the treatment of companion animals cost-effectively and in a timely manner. The accelerated timeline to revenues for veterinary medical devices is a key component of this strategy, which enter the market much earlier than pharmaceuticals and biologics. The product pipeline includes approximately seventeen products intended to treat animals and people. Its patent protection extends to biomaterials, products, production processes, and methods of use provided by the company's portfolio of nineteen patents.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PETV has been successfully added to your 